Drawing for MESOBLAST

USPTO serial 86008550

MESOBLAST

Reviewed by CopyMark Law Group

Reg. 4494438Status 800Registered
Filing date
Status date
Registration date
Mar 11, 2014
Examiner
LOVELACE, JAMES B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with MESOBLAST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, N.W.10th FloorWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the prevention, management, [ diagnosis ] and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the prevention, management, [ diagnosis ] and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the prevention, management, [ diagnosis ] and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; [ diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; ] culture fluids, namely, cultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes but not including embryonic stem cells; human cells including stem cells for medical or clinical use but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatment, reconstruction and repair of tissue but not including preparations for embryonic stem cellsACTIVE
042Scientific, medical research, clinical research, pharmaceutical research and development, advisory and consultancy services in the field of T-cell production, T-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cellsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 24, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 20, 2024NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 20, 2024RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Dec 20, 202489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Dec 20, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2024E89RTEAS SECTION 8 & 9 RECEIVED
Mar 11, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 5, 2020NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 5, 2020C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 5, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 11, 2020E815TEAS SECTION 8 & 15 RECEIVED
Mar 11, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 25, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 19, 2013ALIEASSIGNED TO LIE
Oct 29, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2013XAECEXAMINER'S AMENDMENT ENTERED
Oct 29, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 29, 2013GNEAEXAMINERS AMENDMENT E-MAILED
Oct 29, 2013CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 25, 2013DOCKASSIGNED TO EXAMINER
Jul 19, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance